Crossmark

Direct-to-Consumer Broadcast Advertisements for Pharmaceuticals: Off-Label Promotion and Adherence to FDA Guidelines

Crossref DOI link: https://doi.org/10.1007/s11606-017-4274-9

Published Online: 2018-02-26

Published Print: 2018-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Klara, Kristina

Kim, Jeanie

Ross, Joseph S.
License Information

Text and Data Mining valid from 2018-02-26
More Information

Article History

Received: 31 May 2017

Revised: 28 September 2017

Accepted: 6 December 2017

First Online: 26 February 2018

Compliance with Ethical Standards

:

: In the past 36 months, Dr. Ross has received research support through Yale University from Johnson & Johnson to develop methods of clinical trial data sharing; from Medtronic, Inc. and the Food and Drug Administration (FDA) to develop methods for post-market surveillance of medical devices (U01FD004585); from the Food and Drug Administration to establish the Yale-Mayo Clinic Center for Excellence in Regulatory Science and Innovation (CERSI) program (U01FD005938); from Blue Cross Blue Shield Association to better understand medical technology evaluation; from the Centers for Medicare & Medicaid Services (CMS) to develop and maintain performance measures that are used for public reporting; and from the Agency for Healthcare Research and Quality to examine community predictors of healthcare quality (R01HS022882). All remaining authors declare that they do not have a conflict of interest.